3 results
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓)
of cytochrome p450 CYP3A4 and P-glycoprotein.

DOACs are substrates
) Cancer-treatment ... inducers (↑) and inhibitors ... P-glycoprotein is ... #Chemotherapy #Oncology ... #Hematology #Interactions
Myelodysplastic Syndromes (MDS)

What?
Myelodysplastic syndromes are a group of disorders caused by blood cells that are poorly
(MDS) What? ... Myelogenous Leukemia (CML ... methyltransferase inhibitors ... #diagnosis #hematology ... #oncology
Hemophagocytic Lymphohistiocytosis (HLH)

High mortality without prompt recognition and management. HLH is a critical diagnostic consideration in
hyperinflammatory syndrome ... often a cancer. ... (often termed MAS-HLH ... therapies: JAK inhibitors ... Diagnosis #Management #Hematology